Oregon Public Employees Retirement Fund increased its position in Boston Scientific Corp. (NYSE:BSX) by 29.5% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 329,557 shares of the company’s stock after buying an additional 75,011 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Boston Scientific Corp. were worth $7,843,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. First American Trust FSB boosted its stake in shares of Boston Scientific Corp. by 33.3% in the third quarter. First American Trust FSB now owns 134,341 shares of the company’s stock valued at $3,197,000 after buying an additional 33,588 shares during the period. Evercore Wealth Management LLC boosted its stake in shares of Boston Scientific Corp. by 2.3% in the second quarter. Evercore Wealth Management LLC now owns 10,807 shares of the company’s stock valued at $253,000 after buying an additional 243 shares during the period. Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Boston Scientific Corp. during the second quarter valued at approximately $1,280,000. Kentucky Retirement Systems acquired a new stake in shares of Boston Scientific Corp. during the second quarter valued at approximately $2,697,000. Finally, Northwestern Mutual Investment Management Company LLC boosted its stake in shares of Boston Scientific Corp. by 0.5% in the second quarter. Northwestern Mutual Investment Management Company LLC now owns 51,766 shares of the company’s stock valued at $1,210,000 after buying an additional 283 shares during the period. Institutional investors and hedge funds own 91.45% of the company’s stock.

Institutional Ownership by Quarter for Boston Scientific Corp. (NYSE:BSX)

Boston Scientific Corp. (NYSE:BSX) traded up 0.56% during midday trading on Monday, hitting $21.46. The stock had a trading volume of 7,209,087 shares. The company’s 50 day moving average is $22.45 and its 200 day moving average is $23.11. The company has a market cap of $29.22 billion, a price-to-earnings ratio of 404.91 and a beta of 1.15. Boston Scientific Corp. has a 1-year low of $15.67 and a 1-year high of $24.79.

Boston Scientific Corp. (NYSE:BSX) last issued its quarterly earnings data on Wednesday, October 26th. The company reported $0.27 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.27. The firm earned $2.11 billion during the quarter, compared to the consensus estimate of $2.07 billion. Boston Scientific Corp. had a net margin of 0.99% and a return on equity of 23.25%. The business’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same period last year, the business posted $0.24 earnings per share. On average, equities analysts anticipate that Boston Scientific Corp. will post $1.10 earnings per share for the current fiscal year.

A number of analysts recently issued reports on BSX shares. TheStreet cut Boston Scientific Corp. from a “buy” rating to a “hold” rating in a research report on Thursday, July 28th. Benchmark Co. lifted their price objective on Boston Scientific Corp. from $25.00 to $31.00 and gave the company a “buy” rating in a research report on Thursday, July 28th. Leerink Swann reissued a “buy” rating on shares of Boston Scientific Corp. in a research report on Friday, July 29th. JPMorgan Chase & Co. lifted their price objective on Boston Scientific Corp. from $24.00 to $27.00 and gave the company an “overweight” rating in a research report on Friday, July 29th. Finally, Zacks Investment Research cut Boston Scientific Corp. from a “buy” rating to a “hold” rating in a research report on Monday, October 31st. Five equities research analysts have rated the stock with a hold rating and twenty-one have assigned a buy rating to the company’s stock. Boston Scientific Corp. presently has an average rating of “Buy” and an average price target of $25.70.

About Boston Scientific Corp.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven core businesses: Interventional Cardiology, Peripheral Interventions (PI), Cardiac Rhythm Management (CRM), Electrophysiology (EP), Endoscopy, Urology and Pelvic Health, and Neuromodulation.

5 Day Chart for NYSE:BSX

Receive News & Stock Ratings for Boston Scientific Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific Corp. and related stocks with our FREE daily email newsletter.